» Articles » PMID: 6136757

Detection of Breast Carcinoma Metastases in Bone: Relative Merits of X-rays and Skeletal Scintigraphy

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1983 Sep 10
PMID 6136757
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Of 1116 patients receiving primary treatment for breast carcinoma at the Royal Marsden Hospital since 1976, 651 had an abnormal bone scintigram either at primary diagnosis (378) or on subsequent follow-up (273) and 167 developed radiographically detectable bone metastases (21 at the time of primary diagnosis). Comparison of bone scintigrams and X-rays showed that scintigraphy was an inaccurate localiser of existing radiographic detectable metastases. If X-rays alone are used to detect bone metastases a limited examination with five plates will detect metastases with 92% accuracy. After primary surgery, routine X-ray screening for bone metastases is not necessary since it is possible to identify patients at risk on the basis of clinical examination, chest X-ray, and serum alkaline phosphatase and gamma-glutamyl transpeptidase levels.

Citing Articles

Risk of metastasis among rib abnormalities on bone scans in breast cancer patients.

Li Q, Chen Z, Zhao Y, Li X, Pan H, Xia T Sci Rep. 2015; 5:9587.

PMID: 25939860 PMC: 5386210. DOI: 10.1038/srep09587.


Analysis of clinicopathological factors associated with bone metastasis in breast cancer.

Chen J, Zhu S, Xie X, Guo S, Tong L, Zhou S J Huazhong Univ Sci Technolog Med Sci. 2013; 33(1):122-125.

PMID: 23392720 DOI: 10.1007/s11596-013-1083-1.


The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.

Damle N, Bal C, Bandopadhyaya G, Kumar L, Kumar P, Malhotra A Jpn J Radiol. 2013; 31(4):262-9.

PMID: 23377765 DOI: 10.1007/s11604-013-0179-7.


Whither the PET scan? The role of PET imaging in the staging and treatment of breast cancer.

Gennari A, Piccardo A, Altrinetti V, Corradengo D, Villavecchia G, De Censi A Curr Oncol Rep. 2011; 14(1):20-6.

PMID: 22094933 DOI: 10.1007/s11912-011-0210-z.


Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer.

Tamiya M, Suzuki H, Kobayashi M, Sasada S, Okamoto N, Morishita N Med Oncol. 2011; 29(1):215-8.

PMID: 21258879 DOI: 10.1007/s12032-010-9801-z.